Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Public ClinicalTrials.gov record NCT00105521. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
Study identification
- NCT ID
- NCT00105521
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- EMD Serono
- Industry
- Enrollment
- 398 participants
Conditions and interventions
Conditions
Interventions
- Sarizotan Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 29, 2004
- Primary completion
- Mar 30, 2006
- Completion
- Mar 30, 2006
- Last update posted
- Apr 1, 2018
2004 – 2006
United States locations
- U.S. sites
- 32
- U.S. states
- 15
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85004 | — |
| Not listed | Phoenix | Arizona | 85013 | — |
| Not listed | Phoenix | Arizona | 85032 | — |
| Not listed | Scottsdale | Arizona | 85259 | — |
| Not listed | Fayetteville | Arkansas | 372703 | — |
| Not listed | Fountain Valley | California | 92708 | — |
| Not listed | Los Angeles | California | 90033 | — |
| Not listed | Fort Lauderdale | Florida | 33334 | — |
| Not listed | Hollywood | Florida | 33021 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | Port Charlotte | Florida | 33952 | — |
| Not listed | St. Petersburg | Florida | 33703 | — |
| Not listed | Tampa | Florida | 33612 | — |
| Not listed | Chicago | Illinois | 60611-3078 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Hoffman Estates | Illinois | 60194 | — |
| Not listed | Lexington | Kentucky | 40503 | — |
| Not listed | Baltimore | Maryland | 21207 | — |
| Not listed | Columbia | Maryland | 21044 | — |
| Not listed | Boston | Massachusetts | 02118-2526 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Golden Valley | Minnesota | 55427 | — |
| Not listed | Omaha | Nebraska | 68131 | — |
| Not listed | Albany | New York | 12205 | — |
| Not listed | New York | New York | 10003 | — |
| Not listed | Syracuse | New York | 13210 | — |
| Not listed | Toledo | Ohio | 43614-5811 | — |
| Not listed | Allentown | Pennsylvania | 18103 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Upland | Pennsylvania | 19013 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Charlottesville | Virginia | 22903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00105521, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 1, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00105521 live on ClinicalTrials.gov.